The structures of the synthesized complexes have been confirmed by IR, 1H and 13C NMR spectral data. The data obtained by these techniques are in agreement with each other and support the predicted structures. The complexation of the drug TP with either the PA or DNBA acceptors leads to hydrogen bonding with Liproxstatin-1 transfer, whereas a direct π → π* transition is observed between TP and the CLA or CHL acceptor. Fig. 5S illustrates the proposed structures of the drug TP complexes with the PA, DNBA, CLA and CHL acceptors.
3.1.5. Thermal measurements
Thermal decomposition data for the collenchyma synthesized CT complexes.CompoundStagesTG range (°C)TG% mass lossLost speciesFoundCalculatedTP–PAI165–30099.80100.0PA + TPTP–DNBAI110–22511.2911.73NO2II220–40041.9042.32C7H4O4NIII400–60027.2527.53CH8N4O2Residue–17.8218.356CTP–CLAI150–42064.9265.05TP + 2HClII420–60028.5528.784COResidue–6.06.172CTP–CHLI140–25012.7813.142N2II250–60080.8481.21C11H8Cl4O4Residue–5.075.632CFull-size tableTable optionsView in workspaceDownload as CSV